1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. ResMed Inc (RMD)
  7. Quote


ResMed Stock Price

-1.10 (-0.43%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 489,659
Bid Price
Ask Price
News -
Day High 258.45


52 Week Range


Day Low 252.485
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ResMed Inc RMD NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.10 -0.43% 254.78 20:00:00
Open Price Low Price High Price Close Price Prev Close
257.93 252.485 258.45 254.78 255.88
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,927 489,659 $ 254.13 $ 124,435,191 - 179.37 - 301.34
Last Trade Time Type Quantity Stock Price Currency
19:00:00 72,684 $ 254.78 USD


Draw Mode:

ResMed Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.13B 145.72M 129.03M $ 3.20B $ 476.97M 3.24 74.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 1.56 0.66% 11/09/21 -46.97k 1.70%

more financials information »

ResMed News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week255.24261.25250.44254.75609,118-0.46-0.18%
1 Month262.19275.60250.44258.38524,852-7.41-2.83%
3 Months297.33298.08250.44264.80573,008-42.55-14.31%
6 Months202.51301.34202.00259.58546,14852.2725.81%
1 Year208.36301.34179.37228.87575,07446.4222.28%
3 Years112.00301.3490.64166.48647,347142.78127.48%
5 Years59.74301.3458.71134.88640,748195.04326.48%

ResMed Description

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.